Article metrics

Download PDFPDF

ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer

 

Online download statistics by month:

Online download statistics by month: September 2021 to June 2022

AbstractFullPdf
Sep 2021626312
Oct 2021605573243
Nov 2021316314102
Dec 2021520517109
Jan 202229229172
Feb 2022301306105
Mar 2022319334110
Apr 2022364380135
May 2022305312164
Jun 2022349350155
Total343334401207